Singh et al.
1119
CH3), 3.21 and 3.46 (AB system, 2H, CH2, J = 18 Hz), 7.42
(d, 2H, C2 ′- and C6 ′-H), 8.04 (d, 2H, C3 ′- and C5 ′-H). M+
289. Anal. calcd. for C11H10F3N3O3: C 45.68, H 3.48, N
14.53; found C 45.81, H 3.60, N 14.68.
7.26–7.42 (m, 5H, Ar-H), 7.75–7.82 (m, 3H, C5′-, C6′-, and
C7′-H), 8.53 (s, 1H, C4′-H). M+ 395. Anal. calcd. for
C17H12F3N3O3S: C 51.65, H 3.06, N 10.63; found C 51.42,
H 321, N 10.65.
1-p-Nitrophenyl-3-methyl-5-trifluoromethylpyrazole (3e)
An ethanolic solution of (7e) and 2 mL of conc. HCl was
refluxed for 10 h. The solvent was evaporated and the resi-
1-(2′,4′-Dinitrophenyl)-3-(2-thienyl)-5-trifluoromethyl-5-
hydroxypyrazoline (7s)
This compound was prepared using the procedure de-
1
due crystallized from ethanol, mp 80–81°C, yield 56%. H
1
scribed for 7m, mp 152°C, yield 58%. H NMR (CDCl3) δ:
NMR (CDCl3) δ: 2.36 (CH3), 6.54 (s, 1H, C4-H), 7.72 (d,
2H, C2 ′- and C6 ′-H), 8.33 (d, 2H, C3 ′- and C5 ′-H). M+ 271.
Anal. calcd. for C11H8F3N3O2: C 48.72, H 2.97, N 15.49;
found C 49.01, H 3.11, N 15.39.
4.42 (m, 2H, CH2), 7.28 (m, 1H, C3′′ -H), 7.92 (d, 1H, C4′′ -H),
8.02 (d, 1H, C5′′ -H), 8.04 (d, 1H, C6′-H), 8.44 (dd, 1H, C5′-H),
9.07 (d, 1H, C3′-H). Anal. calcd. for C14H9F3N4O5S: C
41.80, H 2.25, N 13.93; found C 42.03, H 2.41, N 13.71.
1-(1′,2′-Benzisothiazol-3′-yl)-3-methyl-5-trifluoromethyl-5-
hydroxypyrazoline 1′,1′-dioxide (7h)
1-(2′,4′-Dinitrophenyl)-3-(2-thienyl)-5-trifluoromethylpyra-
zole (3s)
An ethanolic solution (50 mL) of 3-hydrazino-2-
benzisothiazole-1′,1′-dioxide (1.2 g, 6 mmol) and sodium ac-
etate (0.5 g, 6 mmol) was refluxed for 15 min. An equimolar
amount of 1,1,1-trifluoropentane-2,4-dione (0.9 g, 6 mmol)
was subsequently added and the solution was refluxed for
2 h. The solvent was evaporated and the residue extracted
with chloroform. The organic phase was dried over anhyd
sodium sulfate and the chloroform distilled off, mp 180°C
Following the same procedure as described for 3m, com-
pound 3s was prepared, mp 61°C, yield 53%. 1H NMR
(CDCl3) δ: 6.88 (s, 1H, C4-H), 6.92–7.80 (m, 5H, ArH), 7.90
(d, 1H, C6′-H), 8.66 (m, 1H, C5′-H), 8.88 (d, 1H, C3′-H).
M+ 384. Anal. calcd. for C14H7F3N4O4S: C 43.76, H 1.84, N
14.58; found 43.71, H 1.56, N 14.61.
1
(ethanol), yield 54%. H NMR (CDCl3 + DMSO-d6) δ: 2.14
1-(1′,2′-Benzisothiazol-3′-yl) 3-(2-thienyl)-5-
trifluoromethyl-5-hydroxypyrazoline-1′,1′-dioxide (7t)
(CH3), 3.38 (m, 2H, CH2), 7.72–7.83 (m, 3H, C5 ′-, C6 ′-, and
C7 ′-H), 8.67 (m, 1H, C4 ′-H). M+ 333. Anal. calcd. for
C12H10F3N3O3S: C 43.25, H 3.02, N 12.61; found C 43.38,
H 2.87, N 12.45.
With the same method used in the case of 7h, compound
1
7t was obtained, mp 190°C, yield 56%. H NMR (CDCl3 +
DMSO-d6) δ: 3.75 (m, 2H, CH2), 7.5–7.7 (m, 3H, thienyl),
8.0–8.3 (m, 3H, C5′-, C6′-, and C7′-H), 8.71 (m, 1H, C4′-H).
M+ 401. Anal. calcd. for C15H10F3N3O3S2: C 44.89, H 2.51,
N 10.47; found C 45.00, H 2.69, N 10.30.
1-(2′,4′-Dinitrophenyl)-3-phenyl-5-trifluoromethyl-5-
hydroxypyrazoline (7m)
An ethanolic solution (50 mL) of 2,4-dinitrophenyl-
hydrazine (0.95 g, 6 mmol) and sodium acetate (0.5 g,
6 mmol) was refluxed for 15 min. An equimolar amount of
benzoyltrifluoroacetone (0.9 g, 6 mmol) was subsequently
added and the solution was refluxed for 4 h. The solvent was
evaporated and the residue crystallized from ethanol, mp
1-(1′,2′-Benzisothiazol-3′-yl)-3-(2-pyridyl)-5-trifluoromethyl-
5-hydroxypyrazoline 1′,1′-dioxide (7v)
With the same method used in the case of 7h, compound
1
7v was obtained, mp 224°C, yield 67%. H NMR (CDCl3 +
1
142°C, yield 54%. H NMR (CDCl3) δ: 4.51 (m, 2H, CH2),
DMSO-d6) δ: 3.70 (AB system, 2H, CH2, J = 19 Hz), 7.70–
7.90 (m, 3H, C5′-, C6′-, and C7′-H), 8.70–8.80 (m, 5H,
pyridine and C4-H of the benzisothiazolyl). M+ 396. Anal.
calcd. for C16H11F3N4O3S: C 48.49, H 2.80, N 14.14; found
C 48.36, H 2.71, N 13.85.
7.38–7.99 (m, 5H, ArH), 8.06 (d, 1H, C6 ′-H), 8.45 (dd, 1H,
C5 ′-H), 9.05 (d, 1H, C3 ′-H). M+ 396. Anal. calcd. for
C16H11F3N4O5: C 48.49, H 2.80. N 14.14; found C 48.22, H
2.66, N 13.81.
1-(2′,4′-Dinitrophenyl)-3-phenyl-5-trifluoromethylpyrazole
(3m)
1-(1′,2′-Benzisothiazol-3′-yl)-3,5-bis-trifluoromethyl-5-
hydroxypyrazoline 1′,1′-dioxide (7ff)
To a solution of 7m (0.2 g, 0.5 mmol) in acetic acid was
added 2 mL of pure sulfuric acid. The mixture was refluxed
for 24 h. The solvent was evaporated and the residue was ex-
tracted with chloroform. The organic phase was dried over
anhyd sodium sulfate and the chloroform distilled off, mp
Using the same method as in the case of 7h, compound
1
7ff was obtained, mp 208°C (ethanol), yield 54%. H NMR
(CDCl3 + DMSO-d6) δ: 3.27 (m, 2H, CH2), 7.8–7.9 (m, 3H,
C5′-, C6′-, and C7′-H), 8.46 (m, 1H, C4′-H). M+ 387. Anal.
calcd. for C12H7F6N3O3S: C 37.22, H 1.82, N 10.85; found
C 36.98, H 2.07, N 10.70.
1
56°C (ethanol), yield 53%. H NMR (CDCl3) δ: 6.84 (s, 1H,
C4-H), 7.30 (m, 1H, C6 ′-H), 7.92 (d, 1H, C5 ′-H), 8.06–9.05
(m, 6 H, Ar-H). M+ 378. Anal. calcd. for C16H9F3N4O4: C
50.80, H 2.40, N 15.07; found C 50.66, H 2.37, N 14.86.
1-(p-Fluorophenyl)-3,5-bis-trifluoromethylpyrazole (9aa)
This compound was prepared like 3c and 4c but using
1-(1′,2′-Benzisothiazole-1′,1′-dioxide)-3-phenyl-5-
trifluoromethyl-5-hydroxypyrazoline (7o)
1,1,1,5,5,5-hexafluoropentane-2,4-dione. Mp 54°C (ethanol),
1
yield 65%. H NMR (CDCl3) δ: 6.97 (s, 1H, C4-H), 7.12
With the same method used in the case of 7i, compound
7o was obtained, mp 160°C (ethanol), yield 48%. H NMR
(CDCl3) δ: 3.35 and 3.69 (AB system, 2H, CH2, J = 18 Hz),
(unresolved dd, 2H, C3′- and C5′-H, J = 8.0 and 8.9 Hz),
7.38 (m, 2H, C2′- and C6′-H). Anal. calcd. for C11H5F7N2: C
44.31, H 1.69, N 9.40; found C 44.28, H 1.41, N 9.12.
1
© 2000 NRC Canada